DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
AZD-4785
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
AZD-4785
×
Maximum Phase:
1
First Approval:
None
UNII:
D43WWD6RDZ
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-816336
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-816336
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H27NO3
Molecular Weight:
341.45
AlogP:
1.94
PSA:
60.77
HBD:
2.0
HBA:
#RotB:
3.0
Source:
IMGN-388
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Vitronectin receptor alpha binding agent
IMGN-388
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
Y-39983
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Rho-associated protein kinase inhibitor
Y-39983
×
Maximum Phase:
1
First Approval:
None
UNII:
00ALI1GAY2
Molecule Type:
Small molecule
Molecular Formula:
C16H16N4O
Molecular Weight:
280.33
AlogP:
2.83
PSA:
83.8
HBD:
3.0
HBA:
#RotB:
3.0
Source:
BMS-984923
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
BMS-984923
×
Maximum Phase:
1
First Approval:
None
UNII:
3I1803DK5Z
Molecule Type:
Small molecule
Molecular Formula:
C22H15ClN2O2
Molecular Weight:
374.83
AlogP:
4.66
PSA:
51.22
HBD:
1.0
HBA:
#RotB:
2.0
Source:
AZADIRACHTA INDICA
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZADIRACHTA INDICA
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG-7444
1
Antibody
Investigational
Unknown
Unknown
Unknown
Fibroblast growth factor receptor 3 inhibitor
RG-7444
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GOLD SODIUM THIOMALATE
1
Small molecule
Investigational
Unknown
Unknown
Lung Neoplasms; Rheumatic Diseases
Unknown
GOLD SODIUM THIOMALATE
×
Maximum Phase:
1
First Approval:
None
UNII:
E4768ZY6GM
Molecule Type:
Small molecule
Molecular Formula:
C4H5AuO4S
Molecular Weight:
346.11
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CENICRIVIROC MESYLATE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
CENICRIVIROC MESYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
R96TV84T21
Molecule Type:
Small molecule
Molecular Formula:
C42H56N4O7S2
Molecular Weight:
793.06
AlogP:
8.74
PSA:
85.69
HBD:
1.0
HBA:
#RotB:
17.0
Source:
RG-7376
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase RAF inhibitor
RG-7376
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MP0250
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MP0250
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTAMTATE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOTAMTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1637.88
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAY1436032
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms
Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor
BAY1436032
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H30F3N3O3
Molecular Weight:
489.54
AlogP:
7.08
PSA:
76.38
HBD:
2.0
HBA:
#RotB:
7.0
Source:
GSK-625433
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-625433
×
Maximum Phase:
1
First Approval:
None
UNII:
2YAD6KT0NT
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O5S
Molecular Weight:
512.63
AlogP:
4.02
PSA:
106.78
HBD:
1.0
HBA:
#RotB:
8.0
Source:
GSK-690693
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
cAMP-dependent protein kinase (PKA) inhibitor
GSK-690693
×
Maximum Phase:
1
First Approval:
None
UNII:
GWH480321B
Molecule Type:
Small molecule
Molecular Formula:
C21H27N7O3
Molecular Weight:
425.49
AlogP:
1.58
PSA:
137.14
HBD:
3.0
HBA:
#RotB:
5.0
Source:
CVN-424
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CVN-424
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NAPHTHALENE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
NAPHTHALENE
×
Maximum Phase:
1
First Approval:
None
UNII:
2166IN72UN
Molecule Type:
Small molecule
Molecular Formula:
C10H8
Molecular Weight:
128.17
AlogP:
2.84
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CYC-065
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms
Unknown
CYC-065
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AGN-201904
1
Small molecule
Investigational
Unknown
Unknown
Peptic Ulcer
Unknown
AGN-201904
×
Maximum Phase:
1
First Approval:
None
UNII:
G0835O03ZM
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O8S2
Molecular Weight:
559.62
AlogP:
3.07
PSA:
146.91
HBD:
1.0
HBA:
#RotB:
10.0
Source:
FGF-1
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FGF-1
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DSTP3086S
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
DSTP3086S
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAR-260301
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase p110-beta subunit inhibitor
SAR-260301
×
Maximum Phase:
1
First Approval:
None
UNII:
33639WNC7Q
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RAD-140
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
RAD-140
×
Maximum Phase:
1
First Approval:
None
UNII:
4O87Q44KNC
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClN5O2
Molecular Weight:
393.83
AlogP:
3.98
PSA:
118.76
HBD:
2.0
HBA:
#RotB:
5.0
Source:
OLAPTESED PEGOL
1
Unknown
Investigational
Unknown
Unknown
Glioblastoma; Pancreatic Neoplasms
Unknown
OLAPTESED PEGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
MTM792B442
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-9977
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Heart Failure; Kidney Diseases
Mineralocorticoid receptor modulator
AZD-9977
×
Maximum Phase:
1
First Approval:
None
UNII:
6C9UKZ0CYE
Molecule Type:
Small molecule
Molecular Formula:
C20H18FN3O5
Molecular Weight:
399.38
AlogP:
1.7
PSA:
96.97
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TEMANOGREL
1
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Serotonin 2a (5-HT2a) receptor inverse agonist
TEMANOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
F42Z27575A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O4
Molecular Weight:
436.51
AlogP:
3.06
PSA:
77.85
HBD:
1.0
HBA:
#RotB:
8.0
Source:
FLUOCINOLONE
1
Small molecule
Investigational
Unknown
Unknown
Wet Macular Degeneration
Unknown
FLUOCINOLONE
×
Maximum Phase:
1
First Approval:
None
UNII:
CT1IX58L9S
Molecule Type:
Small molecule
Molecular Formula:
C21H26F2O6
Molecular Weight:
412.43
AlogP:
0.57
PSA:
115.06
HBD:
4.0
HBA:
#RotB:
2.0
Source:
NONA-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NONA-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VOFATAMAB
1
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms
Unknown
VOFATAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
JMH6YR91PG
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK2879552
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Myelodysplastic Syndromes; Small Cell Lung Carcinoma
Unknown
GSK2879552
×
Maximum Phase:
1
First Approval:
None
UNII:
GT77Z6Y09Z
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O2
Molecular Weight:
364.49
AlogP:
3.74
PSA:
52.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RACLOPRIDE C 11
1
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders; Opioid-Related Disorders; Depressive Disorder
Unknown
RACLOPRIDE C 11
×
Maximum Phase:
1
First Approval:
None
UNII:
GE077RPG04
Molecule Type:
Small molecule
Molecular Formula:
C15H20Cl2N2O3
Molecular Weight:
346.24
AlogP:
2.92
PSA:
61.8
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SALCAPROZIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SALCAPROZIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
X88E147FCU
Molecule Type:
Small molecule
Molecular Formula:
C15H21NO4
Molecular Weight:
279.34
AlogP:
2.55
PSA:
86.63
HBD:
3.0
HBA:
#RotB:
9.0
Source:
TRV-120027
1
Protein
Investigational
Unknown
Unknown
Heart Failure; Severe Acute Respiratory Syndrome
Unknown
TRV-120027
×
Maximum Phase:
1
First Approval:
None
UNII:
J1J4P3PQZD
Molecule Type:
Protein
Molecular Formula:
C43H67N13O10
Molecular Weight:
926.09
AlogP:
-1.91
PSA:
355.05
HBD:
13.0
HBA:
#RotB:
26.0
Source:
BUDIGALIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; HIV Infections; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma
Programmed cell death protein 1 inhibitor
BUDIGALIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
6VDO4TY3OO
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
115
116
117
118
119
120
121
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA